Clinical Trials Browser

Phase 1/2 × Prostatic Neoplasms × XRP6258 × Clear all

NCT02522715 2026-02-24

Enzalutamide and Cabazitaxel in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer

Phase 1/2 Active not recruiting

37 enrolled 10 charts

Prostatic Neoplasms

NCT01505868 2021-07-30

Cabazitaxel With or Without Carboplatin in Treating Patients With Previously Treated Metastatic Castration-Resistant Prostate Cancer

Phase 1/2 Completed

170 enrolled 22 charts

Lymphadenopathy, Prostatic Neoplasms